SAM, Tatva lead on Eric Lifesciences acquisition of Strides Shasun for 500 crore

Eric Lifesciences has acquired Strides’ India branded generics business for an aggregate cash consideration of Rs 500 crore.

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com